Telo Genomics Corp.: Telo Genomics Advances Its Lead Product

Toronto, Ontario--(Newsfile Corp. - January 19, 2022) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces the launch of a validation study to accelerate the commercialization of its

Related Keywords

Montreal , Quebec , Canada , United States , Caen , Basse Normandie , France , Toronto , Ontario , Canadian , American , Hugh Rogers , Sherif Louis , Hans Knecht , Mars Centre , International Myeloma Workshop , American Society Of Hematology , Newsfile Corp , Hospital Mcgill University , Telo Genomics Corp , Francois Baclesse Cancer Center , Venture Exchange , Regulation Services Provider , Jewish General Hospital , Mcgill University , American Society , Telo Genomics , Multiple Myeloma , South Tower , Atelo , Genomics , Orp , Advances , Head , Product , Implements , Utomation , Workflow ,